Patients can now find and book urgent care appointments in 22 states at more than 200 facilities on Zocdoc's marketplace. In 2023, the company saw the volume of new urgent care facilities on Zocdoc grow by nearly 40% month over month on average and urgent care bookings grow by 80% month over month on average.
The $98.9 million investment is going to 59 navigator organizations to help consumers find coverage during the 2023 open enrollment period. One recipient said the funding will be especially helpful as the end of the Covid-19 public health emergency nears, when a projected 15 million people will lose coverage.
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
The company, launched by SSM Health, Presbyterian Healthcare Services and Intermountain Healthcare, aims to create a marketplace for digital tools similar to the application stores on smartphones so that health systems can test and implement new solutions in weeks rather than months.
An examination of health insurers' premium rate filings for 2022 shows that most are not factoring in additional costs or savings, which indicates that they expect health utilization to reach pre-pandemic levels.
A new CMS proposed rule aims to make significant changes to Affordable Care Act marketplaces, including increasing the annual open enrollment period by a month and restoring the duties of navigators who help consumers from underserved populations enroll in plans on the federally facilitated exchange.
CMS has adopted several new rules that will change how the Affordable Care Act exchanges operate next year. These include rules that will lower out-of-pocket consumer spending by $400 and widen eligibility for gaining health coverage outside of the designated ACA open enrollment period.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Insurer participation in the ACA individual marketplace is on the rise and the trend is driven by policy changes at the federal level and the lingering effects of the Covid-19 pandemic.